参考文献/References:
[1]Alfakry H,Malle E,Koyani CN,et al.Neutrophil proteolytic activation cascades:a possible mechanistic link between chronic periodontitis and coronary heart disease[J].Innate Immun,2016,22(1):85-99.
[2]Ali S,Driscoll HE,Newton VL,et al.Matrix metalloproteinase-2 is downregulated in sciatic nerve by streptozotocin induced diabetes and/or treatment with minocycline:Implications for nerve regeneration[J].Exp Neurol,2014,11(261):654-665.
[3]Mahecha AM,Wang H.The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis,metastasis,and prognosis of endometrial cancer[J].Onco Targets Ther,2017(10):4617-4624.
[4]AdhikariN,Mukherjee A,Saha A,et al.Arylsulfonamides and selectivity of matrix metalloproteinase-2:An overview[J].Eur J Med Chem,2017,3(129):72-109.
[5]Fukai F.New Type of Antitumor Agent Targeting the Cell Adhesion Molecule,Integrin[J].Yakugaku Zasshi,2017,137(2):137-139.
[6]Shon SM,Jang HJ,Schellingerhout D,et al.Cytokine Response to Diet and Exercise Affects AtheromatousMatrix Metalloproteinase-2/9 Activity in Mice[J].Circ J.2017,81(10):1528-1536.
[7]Dong M,Zhou C,Ji L,et al.AG1296 enhances plaque stability via inhibiting inflammatory responses and decreasing MMP-2 and MMP-9 expression in ApoE mice[J].Biochem Biophys Res Commun,2017,489(4):426-431.
[8]Lekic A,Brekalo Z,Kvesic A,et al.Crosstalk Between Enzyme Matrix Metalloproteinases 2 and 9 and Regulatory T Cell Immunity in the Global Burden of Atherosclerosis[J].Scand J Immunol,2017,86(1):65-71.
[9]Moura MF,Navarro TP,Silva TA,et al.Periodontitis and Endothelial Dysfunction:Periodontal Clinical Parameters and Levels of Salivary Markers Interleukin-1β,Tumor Necrosis Factor-α, Matrix Metalloproteinase-2,Tissue Inhibitor of Metalloproteinases-2 Complex,and Nitric Oxide[J].J Periodontol,2017,88(8):778-787.
[10]Liu N,Cao Y,Zhu G.Expression of matrix metalloproteinases-2,-9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease[J].ArchOral Biol,2017,75:62-67.
[11]Wu H,Shou X,Liang L,et al.Correlation between plasma angiopoietin-1,angiopoietin-2 and matrix metalloproteinase-2 in coronary heart disease[J].Arch Med Sci,2016,12(6):1214-1219.
[12]Chen X,Qian S,Hoggatt A,et al.Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice[J].Arterioscler Thromb Vasc Biol,2017,37(1):75-83.
[13]Kang H,Ahn DH,Pak JH,et al.Magnobovatol inhibits smooth muscle cell migration by suppressing PDGF-Rβ phosphorylation and inhibiting matrix metalloproteinase-2 expression[J].Int J Mol Med,2016,37(5):1239-1246.
[14]Fernandez Machulsky N,Gagliardi J,Fabre B,et al.Matrix metalloproteinases and psychosocial factors in acute coronary syndrome patients[J].Psychoneuroendocrinology,2016,1(63):102-108.
[15]Kusnierova P,Vsiansky F,Pleva L,et al.Reference intervals of plasma matrix metalloproteinases 2,3,and 9 and serum asymmetric dimethylarginine levels[J].Scand J Clin Lab Invest,2015,75(6):508-513.
[16]Moustardas P,Kadoglou NP,Katsimpoulas M,et al.The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice[J].PLoS One.2014,9(9):e108240.
[17]Zhai X,Chi J,Tang W,et al.Yellow wine polyphenolic compounds inhibit matrix metalloproteinase-2,-9 expression and improve atherosclerotic plaque in LDL-receptor-knockout mice[J].J Pharmacol Sci,2014,125(2):132-141.
[18]董超,马新乔,高军秒,等.血府逐瘀方对动脉粥样硬化大鼠MMP-2 及TIMP-2 的影响[J].医学研究与教育,2014,31(3):1-5.
[19]唐其东,吴平生,侯玉清,等.血浆基质金属蛋白酶2和组织型基质金属蛋白酶抑制剂2水平变化与急性冠状动脉综合征的关系[J].中国动脉硬化杂志,2009,17(5):391-394.
[20]王淑华.幽门螺杆菌感染对冠心病患者血清MMP-2 和MMP-9 的影响[J].医学检验与临床,2013,24(5):29-31.
[21]白图雅.血清MMP-2和IL-6及TNF-α在动脉粥样硬化患者中的表达水平及其与疾病相关性研究[J].内蒙古医学杂志,2013,45(7):776-778.
[22]胡晓雁,肖志杰,申亚巍,等.辛伐他汀对脑动脉粥样硬化患者MMP-2、MMP-9和血脂影响的多中心研究[J].中国生化药物杂,2014,34(8)159-161.
[23]Buraczynska M,Dragan M,Buraczynska K,et al.Matrix metalloproteinase-2(MMP-2)gene polymorphism and cardiovascular comorbidity in type 2 diabetes patients[J].J Diabetes Complications,2015,29(6):829-833.
[24]Bakar F.Cucurbitacin B Enhances the Anticancer Effect of Imatinib Mesylate Through Inhibition of MMP-2 Expression in MCF-7 and SW480 Tumor Cell Lines[J].Anticancer Agents Med Chem,2016,16(6):747-754.
[25]Li Z,Takino T,Endo Y,et al.Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis[J].Cancer Sci,2017,108(3):347-353.
相似文献/References:
[1]张 慧,黄艳群,王 妮,等.基于美国全国住院病人样本的心血管疾病研究进展[J].医学信息,2018,31(07):43.[doi:10.3969/j.issn.1006-1959.2018.06.015]
ZHANG Hui,HUANG Yan-qun,WANG Ni,et al.Research Progress of Cardiovascular Disease Based on National Inpatient Sample[J].Journal of Medical Information,2018,31(04):43.[doi:10.3969/j.issn.1006-1959.2018.06.015]
[2]平兰芝,黄小楼,胡天俊,等.CaMKⅡ在心血管疾病中的研究[J].医学信息,2022,35(10):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
PING Lan-zhi,HUANG Xiao-lou,HU Tian-jun,et al.Research on the Role of CaMKⅡ in Cardiovascular Diseases[J].Journal of Medical Information,2022,35(04):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
[3]李 晶,黄 波.抗血小板药物治疗心血管疾病的研究现状[J].医学信息,2022,35(10):83.[doi:10.3969/j.issn.1006-1959.2022.10.020]
LI Jing,HUANG Bo.Research Status of Antiplatelet Drugs in the Treatment of Cardiovascular Diseases[J].Journal of Medical Information,2022,35(04):83.[doi:10.3969/j.issn.1006-1959.2022.10.020]
[4]汤海霞,班 涛.大黄素与心血管疾病的研究[J].医学信息,2022,35(11):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
TANG Hai-xia,BAN Tao.Research on Emodin and Cardiovascular Diseases[J].Journal of Medical Information,2022,35(04):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
[5]郭俊林,张 立.MMP-2在ST段抬高性心肌梗死中的预后评估价值分析[J].医学信息,2018,31(17):71.[doi:10.3969/j.issn.1006-1959.2018.17.021]
GUO Jun-lin,ZHANG Li.Prognostic Value of MMP-2 in ST-segment Elevation Myocardial Infarction[J].Journal of Medical Information,2018,31(04):71.[doi:10.3969/j.issn.1006-1959.2018.17.021]
[6]徐炜棉,郭金莲,王燕琴,等.铁代谢及铁蛋白与心血管疾病关系的现状分析[J].医学信息,2018,31(22):39.[doi:10.3969/j.issn.1006-1959.2018.22.012]
XU Wei-mian,GUO Jin-lian,WANG Yan-qin,et al.Analysis of the Relationship between Iron Metabolism and Ferritin and Cardiovascular Diseases[J].Journal of Medical Information,2018,31(04):39.[doi:10.3969/j.issn.1006-1959.2018.22.012]
[7]刘瑞芳,赵 华,史红娟,等.益生菌与2型糖尿病心血管疾病的研究进展[J].医学信息,2019,32(18):29.[doi:10.3969/j.issn.1006-1959.2019.18.010]
LIU Rui-fang,ZHAO Hua,SHI Hong-juan,et al.Advances in Research on Probiotics and Cardiovascular Diseases in Type 2 Diabetes[J].Journal of Medical Information,2019,32(04):29.[doi:10.3969/j.issn.1006-1959.2019.18.010]
[8]闫娜娜,李雪萍,李 亚,等.FGF23与心血管疾病的研究进展[J].医学信息,2019,32(19):43.[doi:10.3969/j.issn.1006-1959.2019.19.014]
YAN Na-na,LI Xue-ping,LI Ya,et al.Progress in Research on FGF23 and Cardiovascular Diseases[J].Journal of Medical Information,2019,32(04):43.[doi:10.3969/j.issn.1006-1959.2019.19.014]
[9]袁国铭,陈新利,袁国娜,等.心脏病健康知识系统构建与应用[J].医学信息,2019,32(22):8.[doi:10.3969/j.issn.1006-1959.2019.22.003]
YUAN Guo-ming,CHEN Xin-li,YUAN Guo-na,et al.The Construction and Application of Heart Health Knowledge System[J].Journal of Medical Information,2019,32(04):8.[doi:10.3969/j.issn.1006-1959.2019.22.003]
[10]杨 敏,汤云昭,倪长林.2型糖尿病患者心血管疾病的发病机制[J].医学信息,2020,33(06):56.[doi:10.3969/j.issn.1006-1959.2020.06.017]
YANG Min,TANG Yun-zhao,NI Chang-lin.The Pathogenesis of Cardiovascular Disease in Patients with Type 2 Diabetes[J].Journal of Medical Information,2020,33(04):56.[doi:10.3969/j.issn.1006-1959.2020.06.017]